Prediction of biochemical cure in patients with medullary thyroid cancer
Authors:
Open Access
- 28 February 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 107 (6) , 695-704
Abstract
Background The impact of number of node metastases versus metastatic lymph node ratio versus AJCC node category on biochemical cure in medullary thyroid cancer (MTC) is not well defined. Methods Multivariable logistic regression analysis was used to determine clinical and histopathological variables that contribute to biochemical cure in node‐positive MTC. Results Some 584 of 1026 patients with MTC underwent systematic lymph node dissections for node‐positive disease; 27·4 per cent (54 of 197) were biochemically cured after the initial operation and 13·5 per cent (42 of 310 patients) after repeat surgery. Cured patients had significantly less extrathyroid extension (11–14 versus 33·2–55·6 per cent), fewer lymph node metastases (median 2–4 versus 12–16), a lower metastatic lymph node ratio (median 0·05–0·08 versus 0·23–0·28), and were less likely to have AJCC pN1b disease (56–76 versus 89·9–91·6 per cent) and distant metastases (0 versus 28·4–37·1 per cent) than patients who were not cured. Biochemical cure curves advanced steadily up to 7–12 node metastases and a metastatic lymph node ratio of 0·33, eventually levelling off after 16–17 node metastases and metastatic lymph node ratios of 0·45–0·65. In logistic regression analysis, number of lymph node metastases (odds ratio (OR) 17·24 for more than 20 metastases, OR 5·28 for 11–20 metastases, OR 2·22 for 6–10 metastases), preoperative basal serum calcitonin (OR 6·24 for over 1000 pg/ml), reoperation (OR 5·34) and extrathyroid extension (OR 2·42) independently predicted failure to reach biochemical cure. Conclusion Number of lymph node metastases, unlike metastatic lymph node ratio or AJCC node category, determines likelihood of biochemical cure after initial and repeat surgery for node‐positive MTC.Keywords
This publication has 26 references indexed in Scilit:
- Time to calcitonin normalization after surgery for node-negative and node-positive medullary thyroid cancerBritish Journal of Surgery, 2019
- Incidence and prevalence of sporadic and hereditary MTC in Denmark 1960–2014: a nationwide studyEndocrine Connections, 2018
- Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid CarcinomaThyroid®, 2015
- Biochemical Cure after Reoperations for Medullary Thyroid Carcinoma: A Meta-analysisAnnals of Surgical Oncology, 2014
- The Effect of Extent of Surgery and Number of Lymph Node Metastases on Overall Survival in Patients with Medullary Thyroid CancerThe Journal of Clinical Endocrinology & Metabolism, 2014
- Benefit-Risk Balance of Reoperation for Persistent Medullary Thyroid CancerAnnals of Surgery, 2013
- Prognostic Impact of N Staging in 715 Medullary Thyroid Cancer PatientsAnnals of Surgery, 2013
- Preoperative basal calcitonin and tumor stage correlate with postoperative calcitonin normalization in patients undergoing initial surgical management of medullary thyroid carcinomaSurgery, 2011
- Biomarker-Based Risk Stratification for Previously Untreated Medullary Thyroid CancerThe Journal of Clinical Endocrinology & Metabolism, 2010
- Improved prediction of calcitonin normalization in medullary thyroid carcinoma patients by quantitative lymph node analysisCancer, 2000